iiinova — where your digital self keeps evolving

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 02/10/2026

What if antibiotic access focused not on overuse vs underuse, but optimal use? 📅Join GARDP on 27 Oct, 12:00 PM CET to explore how effective treatments can reach high-burden populations and lessons from zoliflodacin’s Thailand approval. 🔗 Register: tinyurl.com/3xfm77hc @advance-id.bsky.social

122

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 03/09/2026

🎉 That’s a wrap on the ADVANCE-ID Clinical Trial Workshop 2026! 2.5 days of learning, discussions, collaboration & research pitches. A big thank you to our speakers, facilitators, panellists & participants for making it a success! 🌏🔬 #ClinicalTrials #ClinicalResearch #GlobalHealth #Collaboration

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 31/08/2026

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by ADVANCE-ID & WHO. Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats #WHO #statistics #clinical

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 28/08/2026

📢 Join us online for ADVANCE-ID's Clinical Trial Workshop 2026 (31 Aug – 2 Sep), featuring a special WHO Collaborating Centre launch. Register to join virtually via Zoom 💻 🔗 forms.cloud.microsoft/r/XitvsiRUxL #ADVANCE_ID #CTW2026 #WHOCC

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 25/08/2026

Demystify clinical trial design & enhance your research toolkit! 📊✨ Join our statistical seminars: ad-id.co/stats #statistics #stats #clinicaltrials #data #seminar

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 14/08/2026

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by @advance-id.bsky.social & @who.int Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats

1129

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 12/08/2026

🚀 Due to continued interest in our Rapid Diagnostics Open Call, we’re extending the deadline to 30 August 2026! 🗒️ Submit your Expression of Interest now! forms.office.com/r/rt77z5X4fD Find out more: ad-id.co/dt

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 06/08/2026

TREAT-GNB has reached 100 participants! THANK YOU to all site investigators & regional leads for making this milestone possible. As the 1st platform trial for severe Gram-negative bacilli infections, we've enrolled participants across Singapore, China, Thailand, Spain & Australia #TREATGNB #AMR

110

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 04/08/2026

📢 Our Rapid Diagnostics Open Call for AMR closes on 16 August 2026 If you have a rapid diagnostic product—or one in development—that fits our Open Call, share with us by submitting your interest before the deadline: lnkd.in/gr9qWbDD 🔗 Open Call details, TPP and EOI reference form: ad-id.co/dt

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 04/08/2026

It was a productive week for the ADVANCE-ID team in Malaysia as we continue preparations for the TREAT-GNB platform trial. Our visit included engagements with the Institute for Clinical Research (ICR), Malaysia, as well as Universiti Sains Malaysia (USM) and #APSIC2026 Conference.

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 20/07/2026

⏰ Reminder: Our Rapid Diagnostics Open Call for AMR is now accepting submissions. Submit your Expression of Interest (EOI) by 16 August 2026. 📋 lnkd.in/gr9qWbDD Target Product Profile and an EOI reference form are available on our website ad-id.co/dt.

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 17/07/2026

We are delighted to share that our latest research has been published in The Lancet Regional Health – Western Pacific! New antibiotics can only save lives if patients who need them are able to access them. 📄Read the paper here: www.sciencedirect.com/science/arti...

010

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 06/07/2026

Developing innovative rapid diagnostic solutions for Antimicrobial Resistance (AMR)? 🚀 Our Rapid Diagnostics Open Call for AMR is now open! Submit your Expression of Interest at 📋 forms.office.com/r/rt77z5X4fD before 16 August 2026! 🗓️ Find out more at ad-id.co/dt

011

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/06/2026

🚀 Help shape a global community for early-career researchers in antimicrobial R&D. If you're a student, PhD candidate, postdoc, clinician or early-career professional, take 8–10 min #REVIVE survey today. Senior researchers are welcome too! 🔗 office.pulse.ly/1nwkdbgjhe

043

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 24/06/2026

✨ Invitation to join our ADVANCE-ID Seminar Series! Join us for an upcoming online seminar on 10 Jul 2026 (5-6.15pm SGT), featuring European Society of Clinical Microbiology and Infectious Diseases (ESCMID) highlights and a sharing on our Data Governance Guidelines. 🔗 Register here: ad-id.co/s2

112

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 01/07/2026

💻 Missed our webinar? You can now watch (or rewatch) it on our website. 🚨 1 week to go until our Rapid Diagnostics Open Call for AMR! Open Call details and Target Product Profile are now available on the DETECT website: ad-id.co/dt ❓ Have questions? Reach out to the DETECT team via: ad-id.co/dtq

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 01/07/2026

📢 Leadership Update at ADVANCE-ID 🌟 A/Prof Mo Yin, ID physician & clinician-scientist, has been appointed Director of ADVANCE-ID, effective 1 Jul 2026. Prof David Paterson, inaugural Director, transitions to Executive Chair. Read more: ad-id.co/ldrt

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 24/06/2026

112

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 17/06/2026

Our webinar is just one week away Developing a rapid diagnostic for AMR? Join us to: ✅ Understand what technologies we're looking for ✅ What makes a rapid diagnostic clinically useful ✅ Learn about regulatory pathways in Asia and early development considerations ‼️ Register now: lnkd.in/gKNh-wda

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 15/06/2026

📢 Applications Now Open: CDA Short-Term Fellowship FY2026 (Round 2) Are you looking to build or strengthen international collaborations in infectious disease research? Application deadline: 19 June 2026 Email us to find out more: hello@advance-id.network #callforapplications #shorttermfellowship

000

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/06/2026

🌍🎥 #ACC2026 session recordings are now available with subtitles in English, Japanese and Thai. From discovery to clinical development, revisit expert-led discussions across antimicrobial R&D — now more accessible globally. 🔗 Watch: acc-conference.com

001

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 04/06/2026

Developing an affordable AMR rapid diagnostic? Join our webinar on 23 Jun 2026, 6–7 PM SGT. Learn what makes a diagnostic clinically useful, common development gaps, regulatory considerations in Asia, and details of our upcoming open call. Register: ad-id.co/3Slr0xF #AMR @carb-x.bsky.social

020

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 03/06/2026

👇 Now available online in #CID ADVANCE-ID: Conducting Innovative Clinical Trials and Promoting Access for Antibiotics in Asia (Vol. 82, Supplement 5; 15 June 2026) A timely collection of papers on antibiotic evidence generation and access in Asia. 🔗Link: ad-id.co/cid #AMR #CIDJournal #Antibiotics

000

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

International Society of Antimicrobial Chemotherapy @isacworld.bsky.social · 15/05/2026

🌟 One month to apply 🌟 Travel Awards for ICC 2026, Manila Open to Young Investigators (<35) from ISAC Member Societies, including Eastern Europe. Awardees receive €1,000 towards travel + accommodation. Apply now: www.isac.world/awards/young... @heiman-wertheim.bsky.social @souhakanj.bsky.social

022

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 20/05/2026

Happy Clinical Trials Day from ADVANCE-ID! We are grateful to contribute to ongoing work in ID research through studies such as TREAT-GNB, RAPID and Phase II (RIV-CARE), advancing innovation against AMR through collaboration and clinical research. #ClinicalTrialsDay #CTD2026

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 19/05/2026

We are excited to be part of the Philanthropy Asia Summit 2026 (18-20 May'26, Sands Expo and Convention Centre, Marina Bay Sands, #Singapore)! Come visit us at our booth to learn more about our work in ID research, clinical trials, and global collaborations! #PAS2026

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 11/05/2026

Applications Open: 2026 Singapore–Southeast Asia Fellowship (S-SEAF) Supports research collaboration, talent mobility & knowledge exchange (ID focus) Options: 2-year or ≥ 6 months Apply by 1 Aug 2026 🔗https://ad-id.co/42NPdib 📅 Webinar: 19 May 2026 🔗 ad-id.co/3R4mjI0

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 08/05/2026

How do you diagnose and treat Chronic Bacterial Prostatitis (CBP)? Help improve research and clinical care for CBP, a challenging infection in outpatient clinics by helping to complete the practice survey on CBP. ⏱ Takes 5–7 minutes: lnkd.in/ejQFEeDP

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 22/04/2026

📢 Shared opportunity: IE Registry road-testing now open Participating centres are invited to suggest: 1 complex and 1 simple patient per centre using standard registry fields including time taken and suggestions. Deadline: 29 April 2026 Registry field PDFs: www.endocarditis.au

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 15/04/2026

We’re delighted to share that IHRI held its second CAG meeting, reaching a consensus to expand beyond recruitment to engagement across the clinical trial lifecycle - tackling mistrust, power gaps, and legal barriers, and seeking to uncover the truth behind public disengagement.

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 08/04/2026

Our team will be actively presenting at #ESCMID2026 showcasing key work in antimicrobial resistance (AMR), Gram-negative infections, and innovative clinical trial approaches. 📍 Join us from 17–21 April 2026 to connect, learn, and engage with us: ad-id.co/escmid26

110

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 26/02/2026

On 12 February 2026, the ADVANCE-ID team had the opportunity to visit Clinical Research Malaysia (CRM) in Kuala Lumpur — a key driver of Malaysia’s growing clinical trial ecosystem. Read more: www.linkedin.com/feed/update/...

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 05/02/2026

✨Invitation to join our ADVANCE-ID Seminar Series! Join us for an upcoming online seminar on 23 Feb 2026 (5-6pm SGT), featuring our project updates and a time of discussion on collaboration opportunities in the future direction of ADVANCE-ID. 🔗Register here: ad-id.co/s1

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 04/02/2026

@who.int will be running a soft launch of the online course for clinical trials - March 2026 🚀 Clinical research learners are invited to: ✅ Early course access 💬 Interactive learning 📝 Share feedback 🌍 Become course ambassadors EOI deadline: 15 Feb 2026 🔗 ad-id.co/whoct

000

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 28/01/2026

⏰One week to go until #ACC2026! From early antibiotic discovery to real-world clinical use and access, ACC2026 brings together global expertise for 2 days of focused discussion, live Q&A and shared learning. 📅 4–5 Feb 2026 I🌍Free and Online 🔗 Register now: eventsair.pulse.ly/lvlg78hsiq

012

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 21/01/2026

🚀 ACC2026 is coming up soon This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy. Co-organized by GARDP and BSAC 📅 4–5 Feb 2026 |🌍 Online 🔗 Register now: bit.ly/4pSEdt7 @bsacandjac.bsky.social @advance-id.bsky.social

004

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 20/01/2026

📢 Your experience matters — help us enhance lab capacities! Please take the survey and share it with other institutions/hospitals, whether or not they have microbiology labs. Link to survey: lnkd.in/gpv3fJka 📱 You can also scan the QR code to participate

111

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 09/01/2026

On 15 Jan 2026, @gardp.bsky.social will host a online webinar on “5 BY 25”, its 5-year initiative focused on advancing antimicrobial R&D and access. Prof David Paterson will be part of the conversation. ⏰ 16:30-17:30 IST/13:00-14:00 SAST/ 19:00-20:00 GMT+8 Register here: ad-id.co/4pp1PFj #AMR

011

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 08/01/2026

We are growing our team! Join us as a Research Associate and support regional efforts to strengthen community engagement in clinical trials: ad-id.co/4junN8t #WeAreHiring #ClinicalTrials #CommunityEngagement #ResearchAssociate #ADVANCE_ID

011

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 07/01/2026

✨ We’re are pleased to introduce Mrs Tin Tin Win Aye and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile. #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

000

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 05/01/2026

Registrations are open for ACC2026, a free, 2-day online conference on the latest advances in antimicrobial research. Organised by GARDP & BSAC, with collab partners ADVANCE-ID & Mahidol University. 📆 4–5 Feb 2026 🔗 bit.pulse.ly/qmgpewgvig @bsacandjac.bsky.social I @advance-id.bsky.social

002

Reposted by ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/12/2025

💻 GARDP is hosting a webinar on the progress & lessons from 5 BY 25, our multi-year effort to advance new antibiotic treatments that address innovation & access gaps. 📅15 Jan 2026⏰12:00–13:00 CET We'll share key results & what's needed for sustainable innovation. 🔗https://bit.pulse.ly/bmwkjrlg2h

002

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 12/12/2025

On 8 and 9 December, ADVANCE-ID hosted the REACH Asia Online Forum, bringing together experts to discuss the importance of engaging communities for clinical trials. Read more: ad-id.co/4pvjX17

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 08/12/2025

Last week, the ADVANCE-ID team had the opportunity to visit Rumah Sakit Nasional Dr. Cipto Mangunkusumo, #OUCRU #Indonesia, and the Indonesia Clinical Research Center (INA-CRC) teams in #Jakarta. 🔗Read more: ad-id.co/3XGzRcR #ClinicalTrials #collaborate @oucru.bsky.social

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 02/12/2025

We're delighted to share that the our Thai Public Engagement Hub led by the Institute of HIV Research and Innovation (IHRI), Thailand successfully conducted its first Community Advisory Group meeting for the Promoting Community Engagement in Clinical Trials in Asia project. 🔗 ad-id.co/4rwS0aL

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 26/11/2025

✨ We’re are pleased to introduce Mr Huang Xiangyuan and welcome him to the ADVANCE-ID team! Learn more about him in this brief profile. #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

010

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 25/11/2025

🏆 Dr Mo Yin, Deputy Director of ADVANCE-ID, has been awarded the L’Oréal-UNESCO For Women in Science Award 2025 (Singapore)! 👩‍🔬✨ “AMR is a silent pandemic, and this recognition reinforces the urgency of rigorous science.” 👏 🔗 Find out more: ad-id.co/4oeORte #WomenInScience #AMR #NUS #Research

000

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 20/11/2025

CARB-X has released updated eligibility criteria for 2025 Funding Round (opens from 1–12 Dec): therapeutics for Gram‑negative infections and Diagnostics for Salmonella Typhi for low resource settings Join webinars on 4–5 Dec. Find out more: ad-id.co/c1 @carb-x.bsky.social #AMR #GlobalHealth

133

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 19/11/2025

✨ We’re are pleased to introduce Dr Xiao Tingting and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile. #WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

011

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) @advance-id.bsky.social · 12/11/2025

Join us on 8–9 Dec 2025 for the REACH Asia Forum on Community Engagement! Hear from experts and community leaders across the region on strengthening community engagement and participation in health research. Register at 🔗https://ad-id.co/reach2025 #CommunityEngagement

000